Litcius/Paper detail

Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades

Elisabetta Cavalcanti, Vanessa Galleggiante, Sergio Coletta, Elisa Stasi, Marcello Chieppa, Raffaele Armentano, Grazia Serino

2020Frontiers in Oncology19 citationsDOIOpen Access PDF

Abstract

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous tumors that present a wide spectrum of different clinical and biological characteristics. Currently, tumor grading, determined by Ki-67 staining and mitotic counts, represents the most reliable predictor of prognosis. This time-consuming approach fails to reach high reproducibility standards thus requiring novel approaches to support histological evaluation and prognosis. In this study, starting from a microarray analysis of paraffin-embedded tissue specimens, we defined the miRNAs signature for poorly differentiated NETs (G3) compared to well-differentiated NETs (G1 and G2) consisting of 56 deregulated miRNAs. We identified 8 miRNAs that were expressed in all GEP-NETs grades but at different level. Among these miRNAs, miR-96-5p expression level was progressively higher from grade 1 to grade 3; inversely, its target FoxO1 expression decreased from grade 1 to grade 3. Our results reveal that the miRNAs expression profile of GEP-NET is correlated with the tumor grade, showing a potential advantage of miRNA quantification that could aid clinicians in the classification of common GEP-NETs subtypes. These findings could reliably support the histological evaluation of GEP-NETs paving the way toward personalized treatment approaches.

Topics & Concepts

microRNANeuroendocrine tumorsCancer researchMedicineBiologyInternal medicineGeneticsGeneMicroRNA in disease regulationCancer-related molecular mechanisms researchNeuroendocrine Tumor Research Advances